EU Health Claims Report: New Signal for Consumer Protection
EU Health Claims Report: New Signal for Consumer Protection
"Today is an important day for consumer protection and the pharmaceutical industry in the European Union. The European Parliament has adopted an important report on the implementation of the Health Claims Ordinance that has a clear signaling effect. Since 2010, the evaluation of health -related information for botanicals has been exposed to numerous products on the market. Disadvantage for both consumers and for manufacturers of plant drugs.
The general manager of the Federal Association of Pharmaceutical Industry (BPI), Dr. Kai Joachimsen said very positively about this development. He emphasized that the resumption of scientific reviews of health -related information for botanicals is long overdue and that a applicable legal framework has already been present. The demand for a clear demarcation between vegetable drugs and officially unchecked nutritional supplements was also evident.
This decision will also have local effects on Berlin, since the city is an important center for pharmaceutical research and production. The clear demarcation between different types of pharmaceuticals and nutritional supplements will help manufacturers in Berlin to identify their products more clearly and to enable consumers to make an informed purchase decision.
In addition, there is a diverse scene of companies in Berlin that specialize in plant -based ingredients and would benefit from clear regulation. The working group Phytopharmaka industry (AG Phytopharma) is, for example, an important advocacy for the plant drug industry in Germany and would benefit from a clear legal regulation at EU level.
In this sense, the decision of the European Parliament is an important step to protect the health and rights of consumers and at the same time take into account the interests of pharmaceutical industry. It remains to be hoped that the European Commission will now act quickly and implement the applicable legal provisions for the benefit of consumers and manufacturers. ”table with relevant information:
| Company | Products | Use |
| - | - | - |
| AG Phytopharma | Vegetable drugs | Benefits from clear regulation |
| Berlin pharmaceutical industry | Different medicines and nutritional supplements Clear labeling and consumer protection |
Source: bpi Federal Association of the pharmaceutical industry / OTS